Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
524.00    4.00 (0.77%)
Bid:
524.00
Ask:
530.00
Spread: 6.00 (1.145%)
Market Cap: £867.04m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Pre-close Statement

9 Jul 2013 07:00

RNS Number : 8583I
Oakley Capital Investments Limited
09 July 2013
 



9 July 2013

 

Oakley Capital Investments Limited ("OCIL" or the "Company")

 

Pre-close Statement

 

·; NAV (unaudited) expected to be in the range of £1.93 - £1.95, an increase of at least 11% over the last 12 months

 

Oakley Capital Investments Limited (AIM: OCL), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. (the "Limited Partnership" or the "Fund"), announces its pre-close statement for the 6 months ended 30 June 2013.

 

The Company, through its investment in the Limited Partnership, has an indirect interest in each of the Limited Partnership's portfolio companies representing 65% of the Limited Partnership's total commitments.

 

To-date the Limited Partnership has exited four of its portfolio investments achieving a gross money multiple on its cost of investment of 2.6x and IRR of 43%, and returning £109m to the Company. In aggregate across all the disposals to-date, the Limited Partnership has achieved a 14% uplift in realisation proceeds above the previous book value of the relevant investment.

 

The Limited Partnership's portfolio of remaining investments comprises six businesses; Daisy Group plc; Verivox Holdings Limited; Time Out Group (Time Out Limited and Time Out America LLC); Intergenia; Broadstone Pensions and Investments Limited; and Monument Securities Limited. Oakley Capital Limited, OCIL's investment adviser, estimates that the Company's net asset value per share will be in the range of £1.93 - £1.95 (31 December 2012: £1.81) (30 June 2012: £1.74). The OCIL net asset value is made up of cash, the investment in the Limited Partnership and loans provided to the Limited Partnership and a number of the portfolio companies.

 

 

Peter Dubens, Director, commented:

 

"We have had a strong start to 2013 with three exits which have generated attractive returns for the Company.

 

We continue to see strong deal flow and have a number of new investment and portfolio company bolt-on acquisitions under review."

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens

 

FTI Consulting

+44 20 7831 3113

Edward Bridges / Emily Hartman

 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Tom Fyson

 

 

About Oakley Capital Investments Limited ("OCIL")

Oakley Capital Investments Limited is a Bermudian incorporated company listed on AIM. OCIL seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P. and, over time, through co-investment opportunities.

 

 

About Oakley Capital Private Equity L.P. (the "Fund")

Oakley Capital Private Equity L.P., a Bermuda established limited partnership, is an unlisted UK and European mid-market private equity fund with the aim of providing investors with significant long term capital appreciation. The Fund's investment strategy is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Fund seeks to invest in businesses with scale in their industry subsectors, thereby creating a sustainable earnings stream which should command a premium on exit.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUUPMUPWPUR
Date   Source Headline
12th Mar 20207:00 amRNSFinal Annual Results 2019
4th Mar 20207:00 amRNSAcquisition of Globe-Trotter
24th Feb 20207:00 amRNSOakley agrees sale of atHome
30th Jan 20207:00 amRNSDirector Dealing
29th Jan 20207:00 amRNSTrading update for the year ended 31 December 2019
24th Dec 20199:00 amRNSUpdate on Rastreator and Acierto
23rd Dec 20193:06 pmRNSHolding(s) in Company
20th Dec 20194:52 pmRNSDirector/PDMR Shareholding
20th Dec 20193:42 pmRNSTransaction in Own Shares
20th Dec 20192:27 pmRNSShare Buy-Back
16th Dec 20197:00 amRNSAppointment of Non-Executive Director
12th Dec 20197:00 amRNSOakley agrees sale of WebPros to CVC
3rd Dec 20197:00 amRNSHolding(s) in Company
15th Nov 20197:00 amRNSDirector Dealing
15th Nov 20197:00 amRNSDirector Dealing
14th Nov 20193:45 pmRNSTransaction in Own Shares
14th Nov 20197:00 amRNSShare Buy-back
18th Oct 20194:58 pmRNSHolding(s) in Company
13th Sep 20197:00 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSResults for the six months ended 30 June 19
29th Aug 20197:00 amRNSInvestment in leading design company Alessi
23rd Aug 20198:00 amRNSAdmission to the Specialist Fund Segment
23rd Aug 20197:00 amRNSResult of Annual General Meeting
20th Aug 20195:30 pmRNSOakley Capital Investments
15th Aug 20197:00 amRNSAcquisition of Seven Miles
26th Jul 20197:00 amRNSNotice of AGM
24th Jul 20197:00 amRNSTrading update for the six months ended 30 June 19
18th Jul 20196:11 pmRNSPublication of Prospectus
18th Jul 20197:01 amRNSProposed move to SFS & AIM cancellation
18th Jul 20197:00 amRNSDirectorate Change
20th Jun 201912:50 pmRNSAnnual Report and Accounts and Shares in Issue
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
30th May 20197:00 amRNSInspired welcomes Warburg Pincus as an Investor
13th May 201911:52 amRNSAcquisition of Videotel and Seagull
1st May 20197:00 amRNSAcquisition of stake in Rastreator and Acierto
5th Apr 20192:45 pmRNSHolding(s) in Company
2nd Apr 20192:00 pmRNSKepler Trust Intelligence: New Research
25th Mar 20197:00 amRNSAcquisition of Ekon
15th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSShare buy-back
14th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
6th Mar 20194:53 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTrading update for the year ended 31 December 2018
3rd Jan 20197:00 amRNSCapital Commitment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.